A pilot double‐blind placebo‐controlled trial of low‐dose pramipexole in sleep‐related eating disorder
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Sleep‐related eating disorder (SRED) is characterized by recurrent arousals from sleep associated with compulsive ingestion of food. No controlled therapeutic trials are available for SRED. We assessed the safety, tolerability and efficacy of pramipexole, a dopamine D3‐receptor agonist, in the treatment of SRED. Eleven consecutive patients with SRED in the absence of concurrent daytime eating disorders underwent actigraphic recording and subjective sleep diary evaluation for a week before and every week for 2 weeks of treatment with pramipexole 0.18–0.36 mg or placebo, administered in a double‐blind crossover randomized sequence. The primary outcomes of the trial were actigraphic measures of night sleep parameters (sleep efficiency, motor activity mean and median, number and duration of wake episodes), secondary outcomes were the number of good sleep nights/weekly, number and duration of nocturnal awakenings/night, and visual analogue preference score. Pramipexole was well tolerated without any patient withdrawing from the study. Pramipexole reduced night‐time activity median (P = 0.02) and increased the number of nights of good sleep/week (P = 0.02). All other measurements remained unaffected. Pramipexole at low doses was well tolerated, improving some measures of sleep quality and reducing median night activity in SRED. Further studies with higher dosages and for longer time‐periods are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schenck, C. H., & Mahowald, M. W. (2002) · SLEEP · doi:10.1093/sleep/25.2.120 · Cited by 770
Stunkard, A. J., Grace, W. J., & Wolff, H. G. (1955) · The American Journal of Medicine · doi:10.1016/0002-9343(55)90276-x · Cited by 612
Schenck, C. H., Hurwitz, T. D., Bundlie, S. R., & Mahowald, M. W. (1991) · Sleep · doi:10.1093/sleep/14.5.419 · Cited by 175
Additional Categories of Sleep-Related Eating Disorders and the Current Status of Treatment
(1993) · Sleep · doi:10.1093/sleep/16.5.457 · Cited by 156 · cited 1×
“…treatments for nocturnal eating disorders and SRED have been described but nearly all reports have been retrospective, unblinded and not placebo-controlled (Schenck et al., 1993; Mancini and Aloe, 1994; Spaggiari et al., 1994; Schenck and Mahowald, 2002; Winkelman, 2003; O’Reardon et al., 2004).”
Background
Cited by
Morgenthaler, T., Alessi, C., Friedman, L., Owens, J., Kapur, V., Boehlecke, B., Brown, T., Chesson, A., Coleman, J., Lee-Chiong, T., et al. (2007) · Sleep · doi:10.1093/sleep/30.4.519 · Cited by 1,142
Parasomnias: An Updated Review
Howell, M. J. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0143-8 · Cited by 165
Vetrugno, R., Manconi, M., Ferini-Strambi, L., Provini, F., Plazzi, G., & Montagna, P. (2006) · Sleep · doi:10.1093/sleep/29.7.949 · Cited by 136
Self-citationNonREM Disorders of Arousal and Related Parasomnias: An Updated Review
Irfan, M., Schenck, C. H., & Howell, M. J. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01011-y · Cited by 69
Restless Nocturnal Eating: A Common Feature of Willis-Ekbom Syndrome (RLS)
Howell, M. J., & Schenck, C. H. (2012) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.2036 · Cited by 63
“34 In the series published here, we monitored therapy outcome in 44 RLS patients previously unexposed to dopaminergics with and without NE.”
Metadata
- Authors
- Provini, F., Albani, F., Vetrugno, R., Vignatelli, L., Lombardi, C., Plazzi, G., & Montagna, P.
- Venue
- European Journal of Neurology
- Publisher
- Wiley
- Published
- 2005-05-09
- Volume
- 12
- Issue
- 6
- Pages
- 432-436
- ISSN
- 1351-5101 (ISSN-L)
- 1468-1331
- OpenAlex
- W1986359089
- Cited by
- 86
- References
- 4
- FWCI
- 3.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A pilot double‐blind placebo‐controlled trial of low‐dose pramipexole in sleep‐related eating disorder. https://app.cochat.ai/papers/10.1111/j.1468-1331.2005.01017.x
- The paper
- Provini, F., Albani, F., Vetrugno, R., Vignatelli, L., Lombardi, C., Plazzi, G., & Montagna, P. (2005). A pilot double‐blind placebo‐controlled trial of low‐dose pramipexole in sleep‐related eating disorder. European Journal of Neurology. https://doi.org/10.1111/j.1468-1331.2005.01017.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.